B. L. Hazleman

Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial

Ernest Choy, David Isenberg, Toby Garrood et al. · Arthritis & Rheumatism · 2002 · 535 citations

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study.

Alan J. Silman, James J. B. Petrie, B. L. Hazleman et al. · Annals of the Rheumatic Diseases · 1988 · 275 citations · Full text

Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

V Kyle, T. E. Cawston, B. L. Hazleman · Annals of the Rheumatic Diseases · 1989 · 146 citations · Full text

Extracorporeal shock-wave therapy for tendonitis of the rotator cuff: A double-blind, randomised, controlled trial

Cathy Speed, C. Richards, David M. Nichols et al. · Journal of Bone and Joint Surgery - British Volume · 2002 · 120 citations · Full text

Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.

Paul D. Lewis, B. L. Hazleman, R. Hanka et al. · Annals of the Rheumatic Diseases · 1980 · 109 citations · Full text